These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1001 related items for PubMed ID: 26188656

  • 1. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y, Kitajima K, Ishihara T, Sasaki R, Otsuki N, Nibu K, Minamikawa T, Kiyota N, Sugimura K.
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [Abstract] [Full Text] [Related]

  • 2. Preoperative 18F-FDG-PET/CT vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis among Patients with Head and Neck Squamous Cell Carcinoma.
    Cho JK, Ow TJ, Lee AY, Smith RV, Schlecht NF, Schiff BA, Tassler AB, Lin J, Moadel RM, Valdivia A, Abraham T, Gulko E, Neimark M, Ustun B, Bello JA, Shifteh K.
    Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
    [Abstract] [Full Text] [Related]

  • 3. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
    Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY.
    J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901
    [Abstract] [Full Text] [Related]

  • 4. The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction.
    Müller J, Hüllner M, Strobel K, Huber GF, Burger IA, Haerle SK.
    Laryngoscope; 2015 Aug; 125(8):1861-8. PubMed ID: 25892275
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA.
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [Abstract] [Full Text] [Related]

  • 7. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR, Choi YJ, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [Abstract] [Full Text] [Related]

  • 8. Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.
    Evangelista L, Cervino AR, Chondrogiannis S, Marzola MC, Maffione AM, Colletti PM, Muzzio PC, Rubello D.
    Nucl Med Commun; 2014 Feb; 35(2):123-34. PubMed ID: 24220055
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Positron emission tomography-computed tomography: a superior and one-stop shop modality for treated head and neck carcinoma compared with conventional tomography.
    Ichpujani VK, Rao SA, Chaturvedi AK, Dewan AK, Choudhary PS.
    J Oral Maxillofac Surg; 2014 Nov; 72(11):2319-32. PubMed ID: 25438279
    [Abstract] [Full Text] [Related]

  • 11. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
    Yi JS, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY, Roh JL.
    J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
    Kendi AT, Corey A, Magliocca KR, Nickleach DC, Galt J, Switchenko JM, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM.
    Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
    [Abstract] [Full Text] [Related]

  • 13. (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.
    Kim JW, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Br J Cancer; 2013 Dec 10; 109(12):2973-9. PubMed ID: 24149172
    [Abstract] [Full Text] [Related]

  • 14. [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
    Hildebrandt MG, Gerke O, Baun C, Falch K, Hansen JA, Farahani ZA, Petersen H, Larsen LB, Duvnjak S, Buskevica I, Bektas S, Søe K, Jylling AM, Ewertz M, Alavi A, Høilund-Carlsen PF.
    J Clin Oncol; 2016 Jun 01; 34(16):1889-97. PubMed ID: 27001573
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic accuracy of F-18 FDG PET/CECT vs. CECT for detecting recurrence of periampullary carcinoma and its prognostic significance.
    Santhosh S, Mittal BR, Kang M, Kapoor R, Gupta R, Rana S, Bhattacharya A, Bhasin D.
    Abdom Imaging; 2015 Jun 01; 40(5):1131-7. PubMed ID: 25655637
    [Abstract] [Full Text] [Related]

  • 16. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G, Altini C, Notaristefano A, Merenda N, Rubini D, Ianora AA, Asabella AN.
    Rev Esp Med Nucl Imagen Mol; 2014 Jun 01; 33(1):22-7. PubMed ID: 23948509
    [Abstract] [Full Text] [Related]

  • 17. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
    Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V, Schlamann M, Antoch G, Forsting M, Wetter A.
    Eur J Nucl Med Mol Imaging; 2016 Jan 01; 43(1):92-102. PubMed ID: 26243264
    [Abstract] [Full Text] [Related]

  • 18. Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
    Ito K, Yokoyama J, Miyata Y, Toyohara J, Okasaki M, Minamimoto R, Morooka M, Ishiwata K, Kubota K.
    Nucl Med Commun; 2015 Mar 01; 36(3):219-25. PubMed ID: 25369751
    [Abstract] [Full Text] [Related]

  • 19. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP, Boerhout EJ, Pieters-van den Bos IC, Comans EF, Oprea-Lager D, Reinhard R, Hoekstra OS, de Bree R, de Graaf P, Castelijns JA.
    Eur J Radiol; 2014 Jul 01; 83(7):1144-1151. PubMed ID: 24768188
    [Abstract] [Full Text] [Related]

  • 20. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
    Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, Fukuda H.
    Eur J Nucl Med Mol Imaging; 2004 Apr 01; 31(4):590-5. PubMed ID: 14722678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.